An interventional study of 5-FU and Mitomycin in Bleb, sponsored by Shahid Beheshti University of Medical Sciences. Status unknown at 1 site in Iran. Open to participants aged 8 Years and older. Per ClinicalTrials.gov, last updated 2008-06-17.
Sponsored by Shahid Beheshti University of Medical Sciences · Not applicable, Interventional, and Treatment
purpose : to evaluate and compare the effectiveness and complication of 5-FU injections and MMC drop in management of early bleb failure .
Design:Randomized clinical trial Methods:Patients with low injected bleb in first month after filtering or combined surgery with MMC which don't respond to high frequent topical steroids and removal of releasable sutures will be randomize to either 5-FU injection or Mitomycin drop 0.02%.For each patient slit photograph in first day of recruiting,first two weeks and first and third month will be obtained.Patients will follow for at least 3 months and IOP ,bleb configuration will check as primary outcome measures.Preoperative and postoperative data,complications,and the need for further surgical procedures will be evaluated.
44 studies on the registry are indexed under Blister; 2 are open to participants now.
This study's planned enrollment of 40 is below the median of 60 across 33 interventional studies indexed under Blister.
Browse Blister studies →Shahid Beheshti University of Medical Sciences is the lead sponsor of 229 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
5-FU injection has been done
Drug: 5-FU and Mitomycin
Mitomycin drop has been administrated
Drug: 5-FU and Mitomycin
Drug pages: Fluorouracil · Mitomycin
* 5-FU injection 5mg * Mitomycin drop 0.02%
Iop and Bleb height,extent and vascularity
Time frame: At least in 3 months of follow up
complication of 5-FU injection or Mitomycin drop in treatment of early bleb failure
The record gives a start of Jun 2007 and a primary completion of Feb 2009. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jun 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Fluorouracil · Mitomycin
Shahid Beheshti University of Medical Sciences →